keyword
https://read.qxmd.com/read/38568265/2023-reviewers
#21
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 1, 2024: Pediatric Physical Therapy
https://read.qxmd.com/read/38568264/thank-you
#22
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 1, 2024: Pediatric Physical Therapy
https://read.qxmd.com/read/38551313/uptake-and-challenges-with-daily-oral-pre-exposure-prophylaxis-among-men-who-have-sex-with-men-and-transgender-women-suburban-yangon-myanmar
#23
JOURNAL ARTICLE
Ni Ni Tun, Frank Smithuis, Nyan Lynn Tun, Myo Min Min Hteik, Myat Ko Ko, Lutgarde Lynen, Tom Decroo, Eric Florence, Tinne Gils
BACKGROUND: Pre-exposure prophylaxis (PrEP) is effective for human immunodeficiency virus (HIV) prevention in risk groups. We assessed PrEP uptake and 12-month retention among men who have sex with men (MSM) and transgender women (TGW) in Myanmar during the coronavirus disease 2019 pandemic and a political crisis. METHODS: Using prospectively collected data, we assessed the proportion of persons eligible, initiated and retained 12 months on PrEP. We calculated HIV and syphilis incidence among those initiated on PrEP...
March 29, 2024: International Health
https://read.qxmd.com/read/38545952/development-of-injectable-upconversion-nanoparticle-conjugated-doxorubicin-theranostics-electrospun-nanostructure-for-targeted-photochemotherapy-in-breast-cancer
#24
JOURNAL ARTICLE
Amreen Khan, Abhishek Tripathi, Mayuri Gandhi, Jayesh Bellare, Rohit Srivastava
Nanotheranostic-based photochemotherapies with targeted drug delivery have considerably surfaced in cancer therapy. In the presented work, polyethyleneimine-coated upconversion nanoparticles were engineered to conjugate covalently with doxorubicin. Upconversion nanoparticles (UCNP)-Doxorubicin (DOX)/synthesized epidermal growth factor receptor-targeting peptide blended with polymer composite was electrospun and formulated as the injectable dosage form. The size of the UCNP and the nanofiber diameter were assessed as 26...
March 28, 2024: Journal of Biomedical Materials Research. Part A
https://read.qxmd.com/read/38520717/design-of-pd-l1-targeted-lipid-nanoparticles-to-turn-on-pten-for-efficient-cancer-therapy
#25
JOURNAL ARTICLE
Yelee Kim, Jiwoong Choi, Eun Hye Kim, Wonbeom Park, Hochung Jang, Yeongji Jang, Sung-Gil Chi, Dae-Hyuk Kweon, Kyuri Lee, Sun Hwa Kim, Yoosoo Yang
Lipid nanoparticles (LNPs) exhibit remarkable mRNA delivery efficiency, yet their majority accumulate in the liver or spleen after injection. Tissue-specific mRNA delivery can be achieved through modulating LNP properties, such as tuning PEGylation or varying lipid components systematically. In this paper, a streamlined method is used for incorporating tumor-targeting peptides into the LNPs; the programmed death ligand 1 (PD-L1) binding peptides are conjugated to PEGylated lipids via a copper-free click reaction, and directly incorporated into the LNP composition (Pep LNPs)...
March 23, 2024: Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
https://read.qxmd.com/read/38501312/external-stimuli-triggered-photodynamic-and-sonodynamic-therapies-in-combination-with-hybrid-nanomicelles-of-icg-pep-ha-laser-vs-ultrasound
#26
JOURNAL ARTICLE
Xinru Kong, Yanxi Yang, Xueli Ren, Yandai Lin, Yu Shi, Zhe Liu
The concept of combining external medical stimuli with internal functional biomaterials to achieve cancer-oriented treatments is being emergingly developed. Optical and acoustical activations have shown particular promise as non-invasive regulation modalities in cancer treatment and intervention. It is always challenging to leverage the contributions of optical and acoustical stimuli and find appropriate biomaterials to optimally match them. Herein, a type of hybrid nanomicelle (ICG@PEP@HA) containing ICG as a photo/sonosensitizer, an amphiphilic peptide for membrane penetration and hyaluronic acid for cluster determinant 44 (CD44) targeting was fabricated...
March 19, 2024: Nanoscale
https://read.qxmd.com/read/38471990/mitoquinone-mesylate-as-post-exposure-prophylaxis-against-sars-cov-2-infection-in-humans-an-exploratory-single-center-pragmatic-open-label-non-randomized-pilot-clinical-trial-with-matched-controls
#27
JOURNAL ARTICLE
Keren Chen, Nicholas J Jackson, Theodoros Kelesidis
BACKGROUND: An ongoing important need exists to rapidly develop novel therapeutics for COVID-19 that will retain antiviral efficacy in the setting of rapidly evolving SARS-CoV-2 variants and potential future development of resistance of SARS-COV-2 to remdesivir and protease inhibitors. To date, there is no FDA-approved treatment for post-exposure prophylaxis against SAR-CoV-2. We have shown that the mitochondrial antioxidant mitoquinone/mitoquinol mesylate (Mito-MES), a dietary supplement, has antiviral activity against SARS-CoV-2 in vitro and in SARS-CoV-2 infected K18-hACE2 mice...
March 7, 2024: EBioMedicine
https://read.qxmd.com/read/38460146/locomotion-efficiency-in-children-with-cerebral-palsy-experiencing-limited-gross-motor-function-walking-versus-cycling
#28
JOURNAL ARTICLE
Cloé Dussault-Picard, Annie Pouliot-Laforte, Claire Cherriere, Eloïse Houle, Laurent Ballaz
PURPOSE: This study compares cycling and walking efficiency, and energy expenditure in children with bilateral spastic cerebral palsy (CP). In children with CP, locomotion with body weight support aids such as a tricycle is a potential alternative for less exhausting movements. METHODS: Nine children with CP traveled at comfortable speed for 6 minutes by cycling and walking. The energy expenditure index (EEI) and the percentage of the reserve heart rate (%HRR) were calculated...
March 1, 2024: Pediatric Physical Therapy
https://read.qxmd.com/read/38416659/the-impact-of-positive-expiratory-pressure-therapy-on-hyperinflation-in-patients-with-copd
#29
REVIEW
Juliana Ribeiro Fonseca Franco de Macedo, Elinaldo da Conceiçãodos Dos Santos, Gregory Reychler, William Poncin
BACKGROUND: Lung hyperinflation is a typical clinical feature of patients with COPD. Given the association between breathing at elevated lung volumes and the manifestation of severe debilitating symptoms, therapeutic interventions such as positive expiratory pressure (PEP) therapy and its variations (temporary, oscillatory) have been devised to mitigate lung hyperinflation. However, the efficacy of these interventions remains to be conclusively demonstrated. METHODS: A systematic review with meta-analysis of randomized trials was conducted following the PRISMA guidelines...
February 28, 2024: Respiratory Care
https://read.qxmd.com/read/38400612/double-blind-vehicle-controlled-clinical-investigation-of-peptide-os-01-for-skin-rejuvenation
#30
JOURNAL ARTICLE
Alessandra Zonari, Lear E Brace, Nathaniel H O Harder, Claire Harker, Carolina R Oliveira, Mariana Boroni, Juliana L Carvalho
INTRODUCTION: Senescent cells contribute to age-related tissue deterioration, including the skin, which plays important roles in overall health and social interactions. This study aimed to assess the effects of the senotherapeutic peptide, OS-01 (a.k.a. Pep 14), on skin. METHODS: A 12-week split-face, double-blinded, vehicle-controlled study involving 22 participants was conducted. The OS-01-containing formulation was applied to one side of the face, while the other side received an identical control formulation lacking the peptide...
February 23, 2024: Journal of Cosmetic Dermatology
https://read.qxmd.com/read/38385055/myocardial-infarction-with-nonobstructive-coronaries-minoca-following-rabies-postexposure-prophylaxis-a-case-report
#31
Reechashree Dhungana, Prajjwal Pokharel, Chandra Mani Poudel, Raja Ram Khanal, Smriti Shakya, Ratna Mani Gajurel
KEY CLINICAL MESSAGE: This case underscores the importance of considering myocardial infarction with nonobstructive coronary arteries (MINOCA) in patients experiencing acute chest pain following rabies vaccination, emphasizing the need for heightened awareness and further research into the association between MINOCA and Rabies vaccination. ABSTRACT: Rabies is a vaccine-preventable deadly viral disease prevalent in Asia and Africa that causes thousands of deaths annually...
February 2024: Clinical Case Reports
https://read.qxmd.com/read/38379300/slovenia-s-national-hiv-prep-programme-evaluation-of-real-world-implementation
#32
JOURNAL ARTICLE
Jerca Ambrožič, Peter Adamič, Janez Tomažič
BACKGROUND: The aim of our study was to evaluate real-world implementation of Slovenia's national HIV PrEP programme, which is fully covered by our national health insurance. METHODS: In retrospective cohort study we analysed the data from all men who have sex with men (MSM) who were enrolled in PrEP programme of our clinic between 1 January 2022 and 31 December 2022. RESULTS: A total of 190 MSM with an average age of 36.7 years were included in our analysis...
February 20, 2024: International Journal of STD & AIDS
https://read.qxmd.com/read/38378396/diagnosis-prevention-and-treatment-of-infections-in-kidney-transplantation
#33
REVIEW
Joyita Bharati, Urmila Anandh, Camille N Kotton, Thomas Mueller, Aakash K Shingada, Raja Ramachandran
Kidney transplant often is complicated by infections in the recipient from therapy-related and patient-related risk factors. Infections in kidney transplant recipients are associated with increased morbidity, mortality, and allograft dysfunction. There is a predictable timeline after kidney transplant regarding the types of pathogens causing infections, reflecting the net state of immunosuppression. In the early post-transplant period, bacterial infections comprise two thirds of all infections, followed by viral and fungal infections...
February 19, 2024: Seminars in Nephrology
https://read.qxmd.com/read/38376107/real-world-long-term-safety-and-effectiveness-of-turoctocog-alfa-in-the-treatment-of-haemophilia-a-in-japan-results-from-a-multicentre-non-interventional-post-marketing-study
#34
JOURNAL ARTICLE
Azusa Nagao, Ayumi Deguchi, Keiji Nogami
OBJECTIVES: To assess the safety and effectiveness of turoctocog alfa in previously treated patients (PTPs) and previously untreated patients (PUPs) with haemophilia A in a real-world setting in Japan. METHODS: This multicentre, non-interventional, post-marketing study recruited patients with haemophilia A who initiated treatment with turoctocog alfa from 18 sites (08/2014-12/2018). The primary endpoint was adverse events (AEs) during the 2-year study period. RESULTS: The safety and effectiveness analysis set included 39 patients...
December 2024: Hematology (Amsterdam, Netherlands)
https://read.qxmd.com/read/38375582/adverse-drug-reactions-attributed-to-generic-substitution-of-antiretroviral-medications-among-hiv-treatment-and-pre-exposure-prophylaxis-clients-in-british-columbia-canada
#35
JOURNAL ARTICLE
Katherine J Lepik, Olivia L Hunt, Nic Bacani, Lu Wang, Marianne Harris, Junine Toy, Taylor McLinden, Paul Sereda, Linda J Akagi, Erin Ready, Julio Sg Montaner, Rolando Barrios
BACKGROUND: In British Columbia, antiretrovirals (ARVs) for HIV treatment (HIV-Tx) and pre-exposure prophylaxis (PrEP) are free-of-charge through publicly-funded Drug Treatment Programs (DTPs). When available, less costly generics are substituted for brand-name ARVs. We describe the incidence and type of product substitution issue (PSI) adverse drug reactions (ADRs) attributed to generic ARVs. METHODS: Cohorts included DTP clients ≥19 years who received generic ARVs for HIV-Tx (abacavir-lamivudine, emtricitabine-tenofovir DF, efavirenz-emtricitabine-tenofovir DF, atazanavir or darunavir between 01 Jun 2017 and 30 Jun 2022) or PrEP (emtricitabine-tenofovir DF, 01 Apr 2018 to 30 Jun 2022)...
February 2024: Antiviral Therapy
https://read.qxmd.com/read/38373533/mechanism-of-action-of-phthalazinone-derivatives-against-rabies-virus
#36
JOURNAL ARTICLE
Victoire Perraud, Bart Vanderhoydonck, Guillaume Bouvier, Guilherme Dias de Melo, Amuri Kilonda, Mohamed Koukni, Dirk Jochmans, Sophie Rogée, Youcef Ben Khalifa, Lauriane Kergoat, Julien Lannoy, Tina Van Buyten, Nadia Izadi-Pruneyre, Patrick Chaltin, Johan Neyts, Arnaud Marchand, Florence Larrous, Hervé Bourhy
Rabies, a viral zoonosis, is responsible for almost 59,000 deaths each year, despite the existence of an effective post-exposure prophylaxis. Indeed, rabies causes acute encephalomyelitis, with a case-fatality rate of 100 % after the onset of neurological clinical signs. Therefore, the development of therapies to inhibit the rabies virus (RABV) is crucial. Here, we identified, from a 30,000 compound library screening, phthalazinone derivative compounds as potent inhibitors of RABV infection and more broadly of Lyssavirus and even Mononegavirales infections...
February 17, 2024: Antiviral Research
https://read.qxmd.com/read/38367928/a-community-guide-systematic-review-digital-hiv-pre-exposure-prophylaxis-interventions
#37
REVIEW
Emiko Kamitani, Yinan Peng, David Hopkins, Darrel H Higa, Mary M Mullins
INTRODUCTION: HIV preexposure prophylaxis (PrEP) is highly effective when taken as prescribed. Digital health adherence interventions have been identified as effective for improving antiretroviral therapy adherence among people with HIV, but limited evidence exists for PrEP adherence interventions among people without HIV. The purpose of this Community Guide systematic review was to present the characteristics and effectiveness of digital PrEP adherence interventions. METHODS: The author searched the CDC HIV Prevention Research Synthesis cumulative database for digital health interventions with PrEP adherence outcomes published in peer-reviewed journals from 2000 to 2022...
February 16, 2024: American Journal of Preventive Medicine
https://read.qxmd.com/read/38367654/high-performance-production-process-development-and-scale-up-of-an-anti-tslp-nanobody
#38
JOURNAL ARTICLE
Xiaofei Li, Peng Qiao, Yicai Zhang, Guoxin Liu, Min Zhu, Junwei Gai, Yakun Wan
Nanobodies (Nbs) represent a class of single-domain antibodies with great potential application value across diverse biotechnology fields, including therapy and diagnostics. Thymic Stromal Lymphopoietin (TSLP) is an epithelial cell-derived cytokine, playing a crucial role in the regulation of type 2 immune responses at barrier surfaces such as skin and the respiratory/gastrointestinal tract. In this study, a method for the expression and purification of anti-TSLP nanobody (Nb3341) was established at 7 L scale and subsequently scaled up to 100 L scale...
February 16, 2024: Protein Expression and Purification
https://read.qxmd.com/read/38362833/short-term-effects-of-positive-expiratory-pressure-mask-on-ventilation-inhomogeneity-in-children-with-cystic-fibrosis-a-randomized-sham-controlled-crossover-study
#39
JOURNAL ARTICLE
Simone Gambazza, Alessandra Mariani, Riccardo Guarise, Beatrice Ferrari, Federica Carta, Anna Brivio, Sofia Bizzarri, Chiara Castellani, Carla Colombo, Dario Laquintana
BACKGROUND: Can physiotherapy with a positive expiratory pressure (PEP) mask improve peripheral ventilation inhomogeneity, a typical feature of children with cystic fibrosis (cwCF)? To answer this question, we used the nitrogen multiple-breath washout (N2 MBW) test to measure diffusion-convection-dependent inhomogeneity arising within the intracinar compartment (Sacin *VT). METHODS: For this randomized, sham-controlled crossover trial, two N2 MBW tests were performed near the hospital discharge date: one before and the other after PEP mask therapy (1 min of breathing through a flow-dependent PEP device attached to a face mask, followed by three huffs and one cough repeated 10 times) by either a standard (10-15 cmH2 0) or a sham (<5 cmH2 0) procedure on two consecutive mornings...
February 16, 2024: Pediatric Pulmonology
https://read.qxmd.com/read/38360750/delivering-integrated-strategies-from-a-mobile-unit-to-address-the-intertwining-epidemics-of-hiv-and-addiction-in-people-who-inject-drugs-the-hptn-094-randomized-controlled-trial-protocol-the-integra-study
#40
JOURNAL ARTICLE
David Goodman-Meza, Steven Shoptaw, Brett Hanscom, Laramie R Smith, Philip Andrew, Irene Kuo, Jordan E Lake, David Metzger, Ellen A B Morrison, Melissa Cummings, Jessica M Fogel, Paul Richardson, Jayla Harris, Jesse Heitner, Sarah Stansfield, Nabila El-Bassel
BACKGROUND: Persons with opioid use disorders who inject drugs (PWID) in the United States (US) face multiple and intertwining health risks. These include interference with consistent access, linkage, and retention to health care including medication for opioid use disorder (MOUD), HIV prevention using pre-exposure prophylaxis (PrEP), and testing and treatment for sexually transmitted infections (STIs). Most services, when available, including those that address substance misuse, HIV prevention, and STIs, are often provided in multiple locations that may be difficult to access, which further challenges sustained health for PWID...
February 15, 2024: Trials
keyword
keyword
107643
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.